Literature DB >> 35679416

Doubly stereoconvergent crystallization enabled by asymmetric catalysis.

Pedro de Jesús Cruz1, William R Cassels1, Chun-Hsing Chen1, Jeffrey S Johnson1.   

Abstract

Synthetic methods that enable simultaneous control over multiple stereogenic centers are desirable for the efficient preparation of pharmaceutical compounds. Herein, we report the discovery and development of a catalyst-mediated asymmetric Michael addition/crystallization-induced diastereomer transformation of broad scope. The sequence controls three stereogenic centers, two of which are stereochemically labile. The configurational instability of 1,3-dicarbonyls and nitroalkanes, typically considered a liability in stereoselective synthesis, is productively leveraged by merging enantioselective Brønsted base organocatalysis and thermodynamic stereocontrol using a single convergent crystallization. The synthesis of useful γ-nitro β-keto amides containing three contiguous stereogenic centers is thus achieved from Michael acceptors containing two prochiral centers.

Entities:  

Year:  2022        PMID: 35679416      PMCID: PMC9467684          DOI: 10.1126/science.abo5048

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  10 in total

1.  Crystallization-induced diastereoselection: asymmetric synthesis of substance P inhibitors.

Authors:  Philip J Pye; Kai Rossen; Steven A Weissman; Ashok Maliakal; Robert A Reamer; Richard Ball; Nancy N Tsou; R P Volante; Paul J Reider
Journal:  Chemistry       Date:  2002-03-15       Impact factor: 5.236

Review 2.  Asymmetric synthesis of active pharmaceutical ingredients.

Authors:  Vittorio Farina; Jonathan T Reeves; Chris H Senanayake; Jinhua J Song
Journal:  Chem Rev       Date:  2006-07       Impact factor: 60.622

Review 3.  Crystallization-induced diastereomer transformations.

Authors:  Karel M J Brands; Antony J Davies
Journal:  Chem Rev       Date:  2006-07       Impact factor: 60.622

Review 4.  Molecular Complexity as a Driver for Chemical Process Innovation in the Pharmaceutical Industry.

Authors:  Seb Caille; Sheng Cui; Margaret M Faul; Steven M Mennen; Jason S Tedrow; Shawn D Walker
Journal:  J Org Chem       Date:  2019-04-10       Impact factor: 4.354

5.  Curbing the costs of chemical manufacturing.

Authors:  Seb Caille
Journal:  Science       Date:  2019-05-17       Impact factor: 47.728

Review 6.  The many roles of molecular complexity in drug discovery.

Authors:  Oscar Méndez-Lucio; José L Medina-Franco
Journal:  Drug Discov Today       Date:  2016-08-26       Impact factor: 7.851

7.  Bifunctional Iminophosphorane Superbase Catalysis: Applications in Organic Synthesis.

Authors:  Michele Formica; Daniel Rozsar; Guanglong Su; Alistair J M Farley; Darren J Dixon
Journal:  Acc Chem Res       Date:  2020-09-04       Impact factor: 22.384

8.  Organocatalytic aza-Michael-Michael cascade reactions: a flexible approach to 2,3,4-trisubstituted tetrahydroquinolines.

Authors:  Zhen-Xin Jia; Yong-Chun Luo; Yao Wang; Liang Chen; Peng-Fei Xu; Binghe Wang
Journal:  Chemistry       Date:  2012-09-23       Impact factor: 5.236

9.  Asymmetric synthesis of functionalized cyclopentanones via a multicatalytic secondary amine/N-heterocyclic carbene catalyzed cascade sequence.

Authors:  Stephen P Lathrop; Tomislav Rovis
Journal:  J Am Chem Soc       Date:  2009-09-30       Impact factor: 15.419

10.  Highly efficient asymmetric synthesis of sitagliptin.

Authors:  Karl B Hansen; Yi Hsiao; Feng Xu; Nelo Rivera; Andrew Clausen; Michele Kubryk; Shane Krska; Thorsten Rosner; Bryon Simmons; Jaume Balsells; Nori Ikemoto; Yongkui Sun; Felix Spindler; Christophe Malan; Edward J J Grabowski; Joseph D Armstrong
Journal:  J Am Chem Soc       Date:  2009-07-01       Impact factor: 15.419

  10 in total
  1 in total

1.  Crystallization-Enabled Henry Reactions: Stereoconvergent Construction of Fully Substituted [N]-Asymmetric Centers.

Authors:  Pedro De Jesús Cruz; Jeffrey S Johnson
Journal:  J Am Chem Soc       Date:  2022-08-18       Impact factor: 16.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.